A large number of patients cannot take traditional anti-clotting drugs, such as warfarin, because of the risks of internal bleeding and drug interactions.
The National Cancer Institute (NCI), a division of the National Institutes of Health, has recommended the use of a compression device, also known as a lymphedema pump, for the treatment and management of lymphedema.
Because of diminishing reimbursements from Medicare, skilled nursing facilities are increasingly adopting pneumatic compression therapy and other low-cost approaches to preventing deep vein thrombosis (DVT).
Due to a condition commonly caused by deep vein thrombosis (DVT), a New Zealand woman died following a long-haul flight.
For those at risk for blood clotting, long-distance travel, particularly by plane, may seem an untenable luxury.
Recently, a U.S. television personality had a frightening lesson in the dangers of deep vein thrombosis (DVT).
According to the Centers for Disease Control and Prevention (CDC), between 300,000 and 600,000 people in the United States are affected by DVT or pulmonary embolism (PE) each year.
Studies in recent years have clarified the risk of venous thromboembolism (VTE) associated with air and automobile travel. While its nickname with the general public, “Economy-Class Syndrome”, may sound fairly benign, VTE can result in serious injury or death.
A remarkable new portable vascular compression system weighs only one pound and offers a 17-hour battery life.
Christine Wunderlin recently told her story to the Las Vegas Review-Journal. She said that when she underwent a mastectomy during her fight with breast cancer, she also lost the lymph nodes under one arm. As a result, Wunderlin soon suffered from lymphedema, which caused her left arm to swell to twice its normal size. Greg Grambor, president of Vascular PRN, a distributor of pneumatic compression equipment, says Wunderlin's case is not uncommon.